Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.

Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.

<h4>Background</h4>The decline in lung function can be reduced by long-term inhaled corticosteroid (ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD). We aimed to identify which clinical, physiological and non-invasive inflammatory characteristics pr...

Full description

Bibliographic Details
Main Authors: Jiska B Snoeck-Stroband, Therese S Lapperre, Peter J Sterk, Pieter S Hiemstra, Henk A Thiadens, H Marike Boezen, Nick H T Ten Hacken, Huib A M Kerstjens, Dirkje S Postma, Wim Timens, Jacob K Sont, GLUCOLD Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0143793&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0143793&type=printable

Similar Items